Table 5. Frequency of treatment related adverse events.

	Itching and burning (%)* [%]†	Exudation (%) [%]	Edema (%) [%]	Dermatitis (%) [%]	Total
ILMA *	3 (33.3) [17.6]	1 (11.1) [50.0]	5 (55.6) [41.7]	0 (0.0) [0.0]	9 (100)
ILMA + non-silver dressing	8 (61.5) [47.1]	1 (7.7) [50.0]	3 (23.1) [25.0]	1 (7.7) [100]	13 (100)
ILMA + silver dressing	6 (60.0) [35.3]	0 (0.0) [0.0]	4 (40.0) [33.3]	0 (0.0) [0.0]	10 (100)
Total	17 [100]	2 [100]	12 [100]	1 [100]	32 (100) [100]

^*ILMA  =  intralesioinal meglumine antimoniate. (%)  =  % in each treatment group. [%]  =  % in each adverse event group. Fisher's exact test = 0.561.